Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 18, 2024
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
Matthew Biegler Maintained (ZNTL) at Buy with Decreased Target to $25 on, Jun 18th, 2024
Matthew Biegler of Oppenheimer, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Decreased Target from $50 to $25 on, Jun 18th, 2024.
Matthew has made no other calls on ZNTL in the last 4 months.
There is 1 other peer that has a rating on ZNTL. Out of the 1 peers that are also analyzing ZNTL, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Robert Driscoll of "Wedbush" Maintained at Hold with Increased Target to $15 on, Wednesday, February 28th, 2024
